Ethical use of cogniceuticals in the militaries of democratic nations

American Journal of Bioethics

Volumn 8, Issue 2, 2008, Pages 39-41

  Russo, Michael B ^a,d,e   Arnett, Michael V ^a   Thomas, Maria L ^b   Caldwell, John A ^c  

^a Tripler Army Medical Center

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Archinoetics LLC

^d United States Naval Reserve   (United States)

^e TRIPLER ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZHYDRYL DERIVATIVE; CAFFEINE; CENTRAL STIMULANT AGENT; DEXAMPHETAMINE; MODAFINIL; PSYCHOTROPIC AGENT;

CANADA; COGNITION; CULTURAL FACTOR; DRUG EFFECT; ETHICS; EUROPE; FATIGUE; HUMAN; MILITARY MEDICINE; NOTE; POLITICAL SYSTEM; PRACTICE GUIDELINE; PRESCRIPTION; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR PERFORMANCE; SOLDIER; STANDARD; UNITED STATES;

BENZHYDRYL COMPOUNDS; CAFFEINE; CANADA; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; CROSS-CULTURAL COMPARISON; DEMOCRACY; DEXTROAMPHETAMINE; EUROPE; FATIGUE; GUIDELINES AS TOPIC; HUMANS; MILITARY MEDICINE; MILITARY PERSONNEL; PRESCRIPTIONS, DRUG; PSYCHOMOTOR PERFORMANCE; PSYCHOTROPIC DRUGS; UNITED STATES;

EID: 45849150376     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160802015016     Document Type: Note

References (11)

1. Caldwell, J. A., and J. L. Caldwell. 2005. Fatigue in military aviation: An overview of military-approved pharmacological countermeasures. Aviation, Space, and Environmental Medicine 76(7, Suppl.): C39-51.
2. Institute of Medicine Committee on Military Nutrition Research. 2001. Caffeine for the sustainment of mental task performance - formulations for military operations. Washington, D.C.: National Academies Press.
3. Jaeger, H. 2007. A glance at the tip of a big iceberg: Commentary on "Recommendations for the ethical use of pharmacologic fatigue countermeasures in the U.S. military." Aviation, Space, and Environmental Medicine 78(5, Suppl.): B128-130.
4. Juliano, L. M., and R. R. Griffiths. 2004. A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berlin)176(1): 1-29.
5. Meijer, M. 2007. A human performance perspective on the ethical use of cogniceuticals: Commentary on "Recommendations for the ethical use of pharmacologic fatigue countermeasures in the U.S. military." Aviation, Space, and Environmental Medicine 78(5, Suppl.): B131-133.
6. Nielsen, J. 2007. Danish perspective: Commentary on "Recommendations for the ethical use of pharmacologic fatigue countermeasures in the U.S. military." Aviation, Space, and Environmental Medicine 78(5, Suppl.): B134-135.
7. Roedig, E. 2007. German perspective: Commentary on "Recommendations for the ethical use of pharmacologic fatigue countermeasures in the U.S. military." Aviation, Space, and Environmental Medicine 78(5, Suppl.): B136-137.
8. Russo, M. 2007. Recommendations for the ethical use of pharmacologic fatigue countermeasures in the U.S. military. Aviation, Space, and Environmental Medicine 78(5, Suppl.): B119-127.
9. Russo, M. B., J. A. Caldwell, and M. L. Thomas. 2007. Ethical considerations in the use of cogniceuticals as augmented cognition mitigation strategies: Alertness sustaining fatigue countermeasures. In Foundations of augmented cognition, 4th ed., ed. D. D. Schmorrow, D. M. Nicholson, J. M. Drexler, and L.M. Reeves, 112-116. Arlington, Virginia: Strategic Analysis, Inc.
10. Wolfendale, J. Performance-enhancing technologies and moral responsibility in the military. American Journal of Bioethics 8(2): 28-38.
11. Woodcock, J. 1997. A shift in the regulatory approach. Available at: http://www.fda.gov/Cder/present/diamontreal/regappr/sld001.htm (slide 5 of 17) (accessed March 19, 2008).